Federico Chillari, Silvana Parisi, Giacomo Ferrantelli, Chiara Carrubba, Anna Santacaterina, Paola Critelli, Miriam Sciacca, Valeria Venuti, Sara Lillo, Alberto Cacciola, Giuseppe Iatì, Antonio Pontoriero, Angelo Platania, Pietro Delia, Vincenzo Tombolini, Francesca De Felice, Daniela Musio, Corrado Spatola, Anna Brogna, Stefano Pergolizzi
INTRODUCTION AND AIM: Locally advanced head and neck squamous cell carcinoma (LA-Hnscc) is a true therapeutical challenge in the modern era and the scientific community is trying to face this challenge with new therapeutical strategies, including combinations of monoclonal antibodies and radiation therapy. The aim of this study is to evaluate clinical outcomes in LA-Hnscc patients unfit to receive platinum-based chemotherapy, treated with concurrent simultaneous integrated boost-intensity modulated radiotherapy (Sib-Imrt) + cetuximab (Ctx) in daily clinical practice...
May 2024: Recenti Progressi in Medicina